Article in Biomacromolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Alicia S RobangSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0000-0003-3857-9559
Abhishek RoyDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.ORCID 0009-0005-9927-2544
Joseph B Dodd-ODepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.
Dongjing HeGeorge W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0000-0003-1034-4256
Justin V LeSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Andrew C McShanSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Yuhang HuSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Vivek A KumarDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey 07102, United States.ORCID 0000-0001-7536-9281
Anant K ParavastuSchool of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.ORCID 0000-0001-7183-1942
Funding
New Jersey Alliance for Clinical Translational Science: NJ ACTSUL1TR003017 · NCATS · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI PANETTIERI, REYNOLD ALEXANDER · 2019 to 2023
$28.9M
Bioactive Scaffold for TMJ Disc Regeneration by Endogenous Stem/Progenitor CellsR01DE029321 · NIDCR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEE, CHANG HUN · 2020 to 2024
$3.5M
Diversity Supplement for Angiogenic and anti-microbial supports for pulp regenerationR01DE031812 · NIDCR · UNIVERSITY OF HOUSTON · PI Vivek Kumar · 2022 to 2026
$3.3M
Treatment and Mechanisms of Diabetic Fracture HealingR01AR080895 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI DANA T GRAVES, Shuying Yang · 2023 to 2026
$2.0M
Characterizing Alzheimer's Amyloid-beta Oligomer Structures by Solid-State NMR and Cryo-Electron MicroscopyRF1AG073434 · NIA · GEORGIA INSTITUTE OF TECHNOLOGY · PI PARAVASTU, ANANT KRISHNA, ROSENBERRY, TERRONE L · 2022 to 2022
$1.6M
Characterizing Alzheimer's Amyloid-beta Oligomer Structures by Solid-State NMR and Cryo-Electron MicroscopyR01AG073434 · NIA · GEORGIA INSTITUTE OF TECHNOLOGY · PI Shina Caroline Lynn Kamerlin, Anant Krishna Paravastu · 2025 to 2026
$958k
Acellular composite hydrogel scaffolds for volumetric muscle regenerationR21AR079708 · NIAMS · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI GRASMAN, JONATHAN M., KUMAR, VIVEK · 2022 to 2023
We applied solid- and solution-state nuclear magnetic resonance spectroscopy to examine the structure of multidomain peptides composed of self-assembling β-sheet domains linked to bioactive domains. Bioactive domains can be selected to stimulate specific biological responses (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Structural Consequences of Introducing Bioactive Domains to Designer β-Sheet Peptide Self-Assemblies. · full record | OpenQuestion